Virjo Pharma And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.99 Cr
- Revenue Growth 49.35%
- Profit Growth 103.79%
- Ebitda 28.04%
- Net Worth 54.64%
- Total Assets 102.70%
About Virjo Pharma And Chemicals
Virjo Pharma And Chemicals Limited (VPACL) is a Public Limited Indian Non-Government Company incorporated in India on 01 May 2018 (Six years and nine months 15 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.99 Cr.
Vaibhav Jain, Vimal Jain, Himani Chhingavat, and One other member serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304MP2018PLC045699
-
Company No.
045699
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 May 2018
-
Date of AGM
14 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Virjo Pharma And Chemicals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Jain
|
Director | 29-May-2023 | Current |
|
Vimal Jain
|
Director | 25-Jan-2021 | Current |
|
Himani Chhingavat
|
Director | 25-Jan-2021 | Current |
|
Jyoti Chhingavat
|
Director | 01-May-2018 | Current |
Financial Performance of Virjo Pharma And Chemicals.
Virjo Pharma And Chemicals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.35% increase. The company also saw a substantial improvement in profitability, with a 103.79% increase in profit. The company's net worth Soared by an impressive increase of 54.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Virjo Pharma And Chemicals?
In 2023, Virjo Pharma And Chemicals had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Virjo Healthcare Private LimitedVaibhav Jain, Himani Chhingavat and 1 more are mutual person
Charges (Loans)
₹69.92 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 4.80 Cr
- Others : 2.00 Cr
- Standard Chartered Bank : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2021 | Standard Chartered Bank | ₹1.92 M | Open |
| 15 Mar 2021 | Others | ₹2.00 Cr | Open |
| 04 Jan 2019 | State Bank Of India | ₹4.80 Cr | Open |
How Many Employees Work at Virjo Pharma And Chemicals?
Unlock and access historical data on people associated with Virjo Pharma And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Virjo Pharma And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virjo Pharma And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
